Mel Reichman, PhD, a principal investigator at the Lankenau Institute for Medical Research (LIMR), was invited to serve as chairperson of the opening keynote session for the 2015 international joint conference of the European Chemical Biology Symposium (ECBS) and the International Chemical Biology Society (ICBS) held in Berlin, Germany, in October. Read more from Noodls.
LIMR researcher chairs keynote at international chemical biology conference
About Lankenau Institute for Medical Research
Lankenau Institute for Medical Research (LIMR) is a nonprofit biomedical research institute located on the campus of Lankenau Medical Center and is part of Main Line Health. Founded in 1927, LIMR’s mission is to improve human health and well-being. Faculty and staff are devoted to advancing innovative new approaches to formidable medical challenges, including cancer, cardiovascular disease, gastrointestinal disorders and autoimmune diseases, such as diabetes and arthritis. LIMR’s principal investigators conduct basic, preclinical and translational research, using their findings to explore ways to improve disease detection, diagnosis, treatment and prevention. They are committed to extending the boundaries of human health through technology transfer and training of the next generation of scientists and physicians.